Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Jeuveau for Glabellar Lines
NCT04715048Phase 1Active, not recruiting
- Sponsor
- University of Southern California
- Start
- Jan 2021
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in glabellar rhytides, sponsored by University of Southern California. Primary endpoint: Frown Movement Scale at 3 weeks. Started Jan 2021; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT04715048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715048.